[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

Vancomycin Resistant Staphylococcus aureus (VRSA) Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Vancomycin Resistant Staphylococcus aureus (VRSA) Infections Drug pipeline report- 2020 is an annual R&D review of Vancomycin Resistant Staphylococcus aureus (VRSA) Infections pipeline candidates. The...

October 2019 50 pages

Ventilator Associated Pneumonia (VAP) Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Ventilator Associated Pneumonia (VAP) Drug pipeline report- 2020 is an annual R&D review of Ventilator Associated Pneumonia (VAP) pipeline candidates. The report presents the current status of all maj...

October 2019 80 pages

West Nile Virus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

West Nile Virus Infections Drug pipeline report- 2020 is an annual R&D review of West Nile Virus Infections pipeline candidates. The report presents the current status of all major West Nile Virus Inf...

October 2019 50 pages

Western Equine Encephalitis Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Western Equine Encephalitis Drug pipeline report- 2020 is an annual R&D review of Western Equine Encephalitis pipeline candidates. The report presents the current status of all major Western Equine En...

October 2019 40 pages

Yellow Fever Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

US$ 1,529.00

Yellow Fever Drug pipeline report- 2020 is an annual R&D review of Yellow Fever pipeline candidates. The report presents the current status of all major Yellow Fever therapeutic compounds. Detailed in...

October 2019 60 pages

Global Acromegaly Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Acromegaly drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Acromegaly Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 78 pages

Global Actinic (Solar) Keratosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Actinic (Solar) Keratosis drugs Late phase: Phase 3 and in-approval Actinic (Solar) Keratosis drugs Companies involved in the Pipeline- Company overview Snapshot Actinic (Solar) Keratosis therapeutic treatment activities Details for each Actinic (Solar) Keratosis drug ...

August 2019 62 pages

Global Alcohol Addiction Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Alcohol Addiction condition and increased access to investments is encouraging growth of Alcohol Addiction drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Alcohol Addiction drug pipeline for companies to optimize spending levels by understanding ...

August 2019 132 pages

Global Anesthetic Effect Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Anesthetic Effect condition and increased access to investments is encouraging growth of Anesthetic Effect drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Anesthetic Effect drug pipeline for companies to optimize spending levels by understanding ...

August 2019 81 pages

Global Angina (Angina Pectoris) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Angina (Angina Pectoris) drugs Late phase: Phase 3 and in-approval Angina (Angina Pectoris) drugs Companies involved in the Pipeline- Company overview Snapshot Angina (Angina Pectoris) therapeutic treatment activities Details for each Angina (Angina Pectoris) drug ...

August 2019 57 pages

Global Arrhythmias Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Arrhythmias drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Arrhythmias Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 60 pages

Global Arterial Thrombosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Arterial Thrombosis condition and increased access to investments is encouraging growth of Arterial Thrombosis drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Arterial Thrombosis drug pipeline for companies to optimize spending levels by understanding ...

August 2019 49 pages

Global Atrial Fibrillation Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Atrial Fibrillation condition and increased access to investments is encouraging growth of Atrial Fibrillation drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Atrial Fibrillation drug pipeline for companies to optimize spending levels by understanding ...

August 2019 93 pages

Global Attention Deficit Hyperactivity Disorder (ADHD) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... in-approval Attention Deficit Hyperactivity Disorder (ADHD) drugs Companies involved in the Pipeline- Company overview Snapshot Attention Deficit Hyperactivity Disorder (ADHD) therapeutic treatment activities Details for each Attention Deficit Hyperactivity Disorder (ADHD ...

August 2019 142 pages

Global Autism Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Autism drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Autism Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 145 pages

Global Axillary Hyperhidrosis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Axillary Hyperhidrosis condition and increased access to investments is encouraging growth of Axillary Hyperhidrosis drug pipeline. However, despite high levels of pipeline activity ... provide clear and actionable insights into Axillary Hyperhidrosis drug pipeline for companies to optimize spending levels by ...

August 2019 45 pages

Global Batten Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Batten Disease condition and increased access to investments is encouraging growth of Batten Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Batten Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 59 pages

Global Behcet Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Behcet Disease condition and increased access to investments is encouraging growth of Behcet Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Behcet Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 47 pages

Global Binge Eating Disorder Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Binge Eating Disorder drugs Late phase: Phase 3 and in-approval Binge Eating Disorder drugs Companies involved in the Pipeline- Company overview Snapshot Binge Eating Disorder therapeutic treatment activities Details for each Binge Eating Disorder drug ...

August 2019 52 pages

Global Bullous Pemphigoid Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Bullous Pemphigoid condition and increased access to investments is encouraging growth of Bullous Pemphigoid drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Bullous Pemphigoid drug pipeline for companies to optimize spending levels by understanding ...

August 2019 50 pages

Global Burns Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Burns drug pipeline for companies to optimize spending levels by understanding competition, their ... quality checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Burns Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 109 pages

Global Canavan Disease Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Canavan Disease condition and increased access to investments is encouraging growth of Canavan Disease drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Canavan Disease drug pipeline for companies to optimize spending levels by understanding ...

August 2019 35 pages

Global Cancer related Pain Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Cancer related Pain drugs Late phase: Phase 3 and in-approval Cancer related Pain drugs Companies involved in the Pipeline- Company overview Snapshot Cancer related Pain therapeutic treatment activities Details for each Cancer related Pain drug ...

August 2019 125 pages

Global Cerebral Palsy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Cerebral Palsy condition and increased access to investments is encouraging growth of Cerebral Palsy drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Cerebral Palsy drug pipeline for companies to optimize spending levels by understanding ...

August 2019 40 pages

Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... in-approval Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) therapeutic treatment activities Details for each Chronic Inflammatory Demyelinating Polyneuropathy (CIDP ...

August 2019 52 pages

Global Chronic Traumatic Encephalopathy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Chronic Traumatic Encephalopathy drugs Late phase: Phase 3 and in-approval Chronic Traumatic Encephalopathy drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Traumatic Encephalopathy therapeutic treatment activities Details for each Chronic Traumatic Encephalopathy drug ...

August 2019 45 pages

Global Chronic Urticaria Or Hives Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 3 and in-approval Chronic Urticaria Or Hives drugs Companies involved in the Pipeline- Company overview Snapshot Chronic Urticaria Or Hives therapeutic treatment activities Details for each Chronic Urticaria Or Hives drug candidate ...

August 2019 65 pages

Global Cluster Headache Syndrome Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Cluster Headache Syndrome drugs Late phase: Phase 3 and in-approval Cluster Headache Syndrome drugs Companies involved in the Pipeline- Company overview Snapshot Cluster Headache Syndrome therapeutic treatment activities Details for each Cluster Headache Syndrome drug ...

August 2019 45 pages

Global Cognitive Impairment Associated With Schizophrenia (CIAS) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Cognitive Impairment Associated With Schizophrenia (CIAS) drugs Companies involved in the Pipeline- Company overview Snapshot Cognitive Impairment Associated With Schizophrenia (CIAS) therapeutic treatment activities Details for each Cognitive Impairment Associated With ...

August 2019 79 pages

Global Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... . Increased understanding of underlying causes of Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) condition and increased access to investments is encouraging growth of Complex Regional Pain Syndrome (Reflex Sympathetic Dystrophy) drug ...

August 2019 45 pages

Global Contact Dermatitis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Contact Dermatitis condition and increased access to investments is encouraging growth of Contact Dermatitis drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Contact Dermatitis drug pipeline for companies to optimize spending levels by understanding ...

August 2019 46 pages

Global Coronary Artery Disease (Ischemic Heart Disease) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... in-approval Coronary Artery Disease (Ischemic Heart Disease) drugs Companies involved in the Pipeline- Company overview Snapshot Coronary Artery Disease (Ischemic Heart Disease) therapeutic treatment activities Details for each Coronary Artery Disease (Ischemic Heart Disease ...

August 2019 142 pages

Global Critical Limb Ischemia Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 2 Critical Limb Ischemia drugs Late phase: Phase 3 and in-approval Critical Limb Ischemia drugs Companies involved in the Pipeline- Company overview Snapshot Critical Limb Ischemia therapeutic treatment activities Details for each Critical Limb Ischemia drug ...

August 2019 112 pages

Global Deep Vein Thrombosis (DVT) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... 3 and in-approval Deep Vein Thrombosis (DVT) drugs Companies involved in the Pipeline- Company overview Snapshot Deep Vein Thrombosis (DVT) therapeutic treatment activities Details for each Deep Vein Thrombosis (DVT) drug candidate ...

August 2019 45 pages

Global Dental Pain Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Dental Pain condition and increased access to investments is encouraging growth of Dental Pain drug pipeline. However, despite high levels of pipeline activity, increasing ... to provide clear and actionable insights into Dental Pain drug pipeline for companies to optimize spending levels by understanding competition ...

August 2019 35 pages

Global Dilated Cardiomyopathy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Dilated Cardiomyopathy condition and increased access to investments is encouraging growth of Dilated Cardiomyopathy drug pipeline. However, despite high levels of pipeline activity ... provide clear and actionable insights into Dilated Cardiomyopathy drug pipeline for companies to optimize spending levels by ...

August 2019 48 pages

Global Drug Addiction Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Drug Addiction Pipeline candidates- Pre-clinical Phase: Discovery, research, pre-clinical Early Phase: Phase 1 and Phase 2 Drug Addiction drugs Late phase: Phase 3 and in-approval Drug Addiction drugs ...

August 2019 148 pages

Global Dyskinesia Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Dyskinesia drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Dyskinesia Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 121 pages

Global Encephalitis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Encephalitis drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Encephalitis Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 40 pages

Global Encephalomyelitis Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Encephalomyelitis drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Encephalomyelitis Pipeline candidates- Pre-clinical Phase: Discovery ...

August 2019 52 pages

Global Encephalopathy Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Encephalopathy drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Encephalopathy Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 61 pages

Global Epidermolysis Bullosa Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... of Epidermolysis Bullosa condition and increased access to investments is encouraging growth of Epidermolysis Bullosa drug pipeline. However, despite high levels of pipeline activity ... provide clear and actionable insights into Epidermolysis Bullosa drug pipeline for companies to optimize spending levels by ...

August 2019 102 pages

Global Fatigue Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... is structured to provide clear and actionable insights into Fatigue drug pipeline for companies to optimize spending levels by understanding competition, their ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Fatigue Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 49 pages

Global Fibromyalgia Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Fibromyalgia drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Fibromyalgia Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 73 pages

Global Friedreich Ataxia Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Friedreich Ataxia condition and increased access to investments is encouraging growth of Friedreich Ataxia drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Friedreich Ataxia drug pipeline for companies to optimize spending levels by understanding ...

August 2019 82 pages

Global Globoid Cell Leukodystrophy (Krabbe Disease) Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... in-approval Globoid Cell Leukodystrophy (Krabbe Disease) drugs Companies involved in the Pipeline- Company overview Snapshot Globoid Cell Leukodystrophy (Krabbe Disease) therapeutic treatment activities Details for each Globoid Cell Leukodystrophy (Krabbe Disease ...

August 2019 43 pages

Global Graves Diseases Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... causes of Graves Diseases condition and increased access to investments is encouraging growth of Graves Diseases drug pipeline. However, despite high levels of pipeline activity, ... to provide clear and actionable insights into Graves Diseases drug pipeline for companies to optimize spending levels by understanding ...

August 2019 45 pages

Global Guillain-Barre Syndrome Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Guillain-Barre Syndrome condition and increased access to investments is encouraging growth of Guillain-Barre Syndrome drug pipeline. However, despite high levels of pipeline activity ... provide clear and actionable insights into Guillain-Barre Syndrome drug pipeline for companies to optimize spending levels by ...

August 2019 49 pages

Global Hidradenitis Suppurativa Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... Hidradenitis Suppurativa condition and increased access to investments is encouraging growth of Hidradenitis Suppurativa drug pipeline. However, despite high levels of pipeline activity ... provide clear and actionable insights into Hidradenitis Suppurativa drug pipeline for companies to optimize spending levels by ...

August 2019 62 pages

Global Hyperalgesia Drug Pipeline Trends 2019: Discovery, Pre-clinical, Clinical, In Approval Therapeutics, Companies and Markets

US$ 1,619.00

... structured to provide clear and actionable insights into Hyperalgesia drug pipeline for companies to optimize spending levels by understanding competition, ... checks at each stage to evaluate trends, analysis and forecasts. Scope of the Research Hyperalgesia Pipeline candidates- Pre-clinical Phase: Discovery, ...

August 2019 45 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers